Research And Markets Research And Markets
0 CHECKOUT
Biotechnology Markets in China - Product Image

Biotechnology Markets in China

  • ID: 29803
  • March 2016
  • Region: China
  • 256 Pages
  • AMID Co
1 of 5
China's Demand for Biotechnology will Continue to Grow at About 12% by 2025

China's demand for Biotechnology has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2005, 2010 and 2015) and long-term forecasts through 2020 and 2025 are presented.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

These market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous READ MORE >

Note: Product cover images may vary from those shown
2 of 5

I. INTRODUCTION

Report Scope and Methodology
Executive Summary

II. BUSINESS ENVIRONMENT

Economic Outlook
Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade
Financial and Tax Regulations
Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties

III. BIOTECHNOLOGY INDUSTRY ASSESSMENTS

Transgenic Agricultural Product Outlook
Biotechnology Pharmaceuticals Industry Structure
Market Size
Market Growth Drivers
Major Producer Facility Locations and Output
Market Share of Key Producers
Labor Costs
Potential Entrants
Major End-Users
Major Distributors
Major Foreign Investments
Technology Development

IV. BIOTECHNOLOGY PRODUCTS SUPPLY AND DEMAND

Overview
Biotechnology in Agriculture
Transgenic Agricultural Products Output
Transgenic Crops
Transgenic Fruits and Vegetables
Transgenic Seeds and Plants
Transgenic Oil Crops
Other Transgenic Products in Agriculture
Biopesticides
Animal Growth Hormones
Biotechnology Pharmaceuticals
Biotechnology Vaccines
CSF
Recombinant Human Erythropoietin (r-EPO)
Recombinant Human Insulin
Recombinant Human Growth Hormones
Recombinant Interferon
Other Biotechnology Pharmaceuticals
Demand of Biotechnology Pharmaceutical by Region
Biotechnology Pharmaceutical Imports and Exports
Pricing Trend

V. BIOTECHNOLOGY PRODUCTS CONSUMPTION BY MARKET

Biotechnology Markets Outlook Overview
Agriculture
Agricultural Products Output
Farming Regions
Biotechnology Products Consumption in Agriculture
Pharmaceuticals
Pharmaceutical Market Outlook
Biotechnology Consumption in Pharmaceuticals

VI. MARKET ENTRY CHANNELS

China Market Entry Overview
China’s Distribution System
Biotechnology Products Distribution Channels
Transportation and Freight Infrastructure
Communications

China’s Market Entry
Licensing
Franchising
E-commerce
Trading Companies and Local Agents
Representative Offices and Chinese Subsidiaries
Wholly Foreign Owned Enterprise

VII. BIOTECHNOLOGY PRODUCTS PRODUCER DIRECTORY

Biotechnology Pharmaceutical Producer Profiles and Directory
Distributors and Trading Companies
Research Institutions and Associations
Major End-Users

0BLIST OF TABLES

I. INTRODUCTION

Economic Outlook Summary

II. BUSINESS ENVIRONMENT

Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade

III. BIOTECHNOLOGY INDUSTRY ASSESSMENTS

Biotechnology Pharmaceuticals Industry Output in China
Major Producer Facility Locations
Major Biotechnology Pharmaceutical Producers’ Output
Market Share of Key Producers
Major End-Users
Major Foreign Investments

IV. BIOTECHNOLOGY PRODUCTS SUPPLY AND DEMAND

Biotechnology Products Production and Demand
Transgenic Crops Production and Demand
Transgenic Fruits and Vegetables Production and Demand
Transgenic Seeds and Plants Production and Demand
Transgenic Oil Crops Production and Demand
Other Transgenic Products in Agriculture Production and Demand
Biopesticides Production and Demand
Animal Growth Hormones Production and Demand
Biotechnology Vaccines Production and Demand
CSF Production and Demand
r-EPO Production and Demand
Recombinant Human Insulin Production and Demand
Recombinant Human Growth Hormones Production and Demand
Recombinant Interferon Production and Demand
Other Biotechnology Pharmaceuticals Production and Demand
Demand of Biotechnology Pharmaceuticals by Region
Biotechnology Pharmaceuticals Imports and Exports

V. BIOTECHNOLOGY CONSUMPTION BY MARKET

Total Biotechnology Consumption by Market
Agricultural Product Output
Cultivated Areas Distribution in China
Biotechnology Products Consumption in Agriculture
Pharmaceuticals Market Outlook
Biotechnology Products Consumption in Pharmaceuticals

LIST OF CHARTS

I. INTRODUCTION

China’s Biotechnology Pharmaceuticals Output and Demand

II. BUSINESS ENVIRONMENT

China’s GDP and Growth Rate
Industrial Output by Ownership
China’s Imports and Exports

III. BIOTECHNOLOGY INDUSTRY ASSESSMENTS

Biotechnology Pharmaceuticals Industry Output in China

IV. BIOTECHNOLOGY PRODUCTS SUPPLY AND DEMAND

Biotechnology in Agriculture Production and Demand
Biotechnology Pharmaceuticals Production and Demand
Biotechnology Pharmaceuticals Exports and Imports

VI. MARKETING STRATEGIES

China’s Distribution Channel

Note: Product cover images may vary from those shown
3 of 5



Focus on China’s Healthcare for 1.3 Billion People

In the two past decades, the healthcare industry has been growing at a fast pace. It is a tremendous challenge to provide healthcare for 1.3 billion people. The dramatic expansions of the healthcare system, drug manufacturing, and health insurance have transformed China’s society and economy. Life expectancy reached 76.8 for women and 72.5 for men now comparing to 69.9 for women and 66.9 for men in 1990. Demographic transition from high mortality to low mortality has helped increase life expectancy. Primary diseases have also shifted from infectious to chronic. Cancer, heart diseases and cerebrovascular diseases are now top killers. Spending on healthcare counts for over 5% of GDP now and continue to increase in the next decade.

Healthcare reform has been one of the key topics on the government agenda in China. Due to the rise in the cost of healthcare, more than 10% of the income is spent on healthcare, which is greater than that spent on education and transportation. The rise in the cost in healthcare would definitely have an outcome of the high cost of the drugs.

There are approximately 4,500 pharmaceutical companies in China, the majority of which are small players with limited local market reach. Rapid consolidation between medium and large players in the sector is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to better control the pricing of drugs.

China is one of the world’s major producers of pharmaceuticals. Far outpacing other economies in the world, China is the world’s fastest growing pharmaceutical market. Although China has enjoyed the benefits of an expanding market for pharmaceutical production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector’s economies of scale have yet to be achieved. Most domestic manufacturers in the pharmaceutical industry lack the autonomic intellectual property and financial resources to develop their own brand name products. Most manufacturers rely on the repetitive production of Chinese medicine, low value-added bulk pharmaceuticals or generic drugs.

Biotechnology is a rapidly growing sector in China. Both production and demand have witnessed significant surges in recent years. China will continue to remain a large importer for biotechnology pharmaceuticals to meet the growing domestic demand. Major imports include biotechnology vaccines, CSF, r-EPO, recombinant human insulin, recombinant human growth hormones, recombinant interferon, and other biotechnology pharmaceuticals.

The health care insurance industry of China includes two main parts such as the social healthcare insurance controlled by the government and commercial healthcare insurance provided by private companies. At present, the social healthcare insurance is under reforms to control the increasing healthcare costs. The development of commercial healthcare insurance in China is not inadequate. But the commercial healthcare insurance market has a great growth potential. Today, China has the largest healthcare market in the world. The Chinese healthcare industry is one of the fastest-growing sectors in China, growing at double digit rate each year. Tremendous fast-growing markets for imports and business opportunities for companies around the world.

Note: Product cover images may vary from those shown
4 of 5

- Hangzhou Tianyuan Biological Drug Industry Corp.
- Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown

RELATED PRODUCTS from Db